Overview

Description

  • NatureRecombinant
  • SourceEscherichia coli
  • Amino Acid Sequence
    • SpeciesHuman
    • SequenceLRELRCVCLQ TTQGVHPKMI SNLQVFAIGP QCSKVEVVAS LKNGKEICLD PEAPFLKKVI QKILDGGNKE N

Associated products

Specifications

Our Abpromise guarantee covers the use of ab50039 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Biological activityBiological Activity : Determined by its ability to chemoattract human neutrophils using a concentration range of 10.0-100.0 ng/ml.
  • Applications

    SDS-PAGE

    Functional Studies

  • Endotoxin level< 0.100 Eu/µg
  • FormLyophilised
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. The lyophilized protein is stable for a few weeks at room temperature. Store at -20°C long term.

    This product is an active protein and may elicit a biological response in vivo, handle with caution.

General Info

  • Alternative names
    • AMCFII
    • C-X-C motif chemokine 5
    • chemokine (C-X-C motif) ligand 5
    • Cxcl5
    • CXCL5_HUMAN
    • ENA-78 (8-78)
    • ENA-78(1-78)
    • ENA-78(9-78)
    • ENA78
    • Epithelial derived neutrophil activating protein 78
    • Epithelial-derived neutrophil-activating protein 78
    • Lipopolysaccharide-induced CXC chemokine
    • Neutrophil activating peptide ENA 78
    • Neutrophil-activating peptide ENA-78
    • neutrophil-activating protein 78
    • SCYB5
    • Small inducible cytokine B5
    • small inducible cytokine subfamily B (Cys-X-Cys), member 5 (epithelial-derived neutrophil-activating peptide 78)
    • small inducible cytokine subfamily B, member 5
    • Small-inducible cytokine B5
    see all
  • FunctionInvolved in neutrophil activation. In vitro, ENA-78(8-78) and ENA-78(9-78) show a threefold higher chemotactic activity for neutrophil granulocytes.
  • Sequence similaritiesBelongs to the intercrine alpha (chemokine CxC) family.
  • Post-translational
    modifications
    N-terminal processed forms ENA-78(8-78) and ENA-78(9-78) are produced by proteolytic cleavage after secretion from peripheral blood monocytes.
  • Cellular localizationSecreted.
  • Information by UniProt

References for Recombinant human CXCL5 protein (ab50039)

ab50039 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab50039.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"